The Buried
Footnote Forensic Linguistics Analysis
on Corporate Disclosure Documents
Year-over-Year Drift ZYME
← Back

Certainty language minus hedging language in Risk Factors. Positive = assertive, negative = hedging-heavy.

10-K 2023-03-07 10-K 2024-03-06 10-K 2025-03-05 10-K 2026-03-02

From 2023-03-07 (10-K) to 2026-03-02 (10-K), this metric decreased across 4 filings.


Risk-factor drift item_1a vs prior same-form filing, cosine similarity

  • 10-K 2026-03-02 vs 2025-03-05 99.3% boilerplate
  • 10-K 2025-03-05 vs 2024-03-06 99.6% boilerplate
  • 10-K 2024-03-06 vs 2023-03-07 95.0% boilerplate


Auditor’s report opinion, going-concern & control flags, critical audit matters

  • 10-K 2026-03-02 unqualified 1 CAM · auditor since 2015
    • Revenue recognition from drug supply for ongoing studies from Jazz Pharmaceuticals Ireland Limited (Jazz)
  • 10-K 2025-03-05 unqualified 1 CAM · auditor since 2015
    • Revenue recognition from drug supply for ongoing studies from Jazz Pharmaceuticals Ireland Limited (Jazz)
  • 10-K 2024-03-06 unqualified 1 CAM · auditor since 2015
    • Evaluation of the contract modification related to the amended collaboration agreement with Jazz Pharmaceuticals Ireland Limited (“Jazz”)
  • 10-K 2023-03-07 unqualified 1 CAM · auditor since 2015
    • Evaluation of distinct performance obligations related to the license and collaboration agreement with Jazz Pharmaceuticals Ireland Limited

Balance-sheet trends inventory, receivables, reserves & impairment vs prior year

  • Receivables building faster than sales FY 2024-12-31
    receivables +187% vs revenue +0% · DSO 93.5→267.0 days

Balance-sheet language forensic risk vocabulary shifting in MD&A / financials vs prior year

  • Impairment risk language + numbers
    density 0.85→1.34 / 10k chars (34→49 mentions)

Revenue-recognition drift rev-rec policy language change vs prior filing

  • 10-K 2026-03-02 93% similar to prior accounting-standard adoption
  • 10-K 2025-03-05 85% similar to prior accounting-standard adoption
    + Point IN TIME
  • 10-K 2024-03-06 91% similar to prior accounting-standard adoption
    − Performance Obligations− Standalone Selling Price